Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia
Clinical trial NCT04332913 · UNKNOWN
Trial details
- NCT number
- NCT04332913
- Sponsor
- University of L'Aquila
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-01
- Primary completion
- 2020-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.